GENE ONLINE|News &
Opinion
Blog

Patent
Merck Faces Patent Battle with Halozyme Over Latest Keytruda Injection
2025-03-09
US Court Rules Novartis Blockbuster Multiple Sclerosis Drug’s Patent Invalid
2022-06-22
Bristol Myers Squibb Requests $1.2 Billion Patent Revival From Supreme Court
2022-06-17
Illumina to Pay BGI $333M Following Infringement Case
2022-05-09
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
Gilead’s Kite Wins Legal Battle Against BMS, Gets Its $1.2B Fine Overturned
2021-08-27
From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships
2021-06-18
How Does China Tackle the Issue of Patent Protection? A Deepdive into China’s Patent Trends
2021-03-19
Mainstream Generic Drugs Become Stumbling Blocks for Drug Innovation: A Deepdive into China’s Patent Trends
2021-03-17
Taiwan’s TTY Biopharm Pushes for Clinical Trials of its Complex Cancer Generic Drugs in Europe
2021-02-10
Watching Biosimilar Entrants Alongside Blockbuster Patent Expiry Countdown
2018-09-25
May 14, 2005: Piggybac as a Genetic Manipulation Tool for Analyzing Vertebrates, Patent Application Submitted to WIPO
2018-05-15
April 4, 1938: Celebrate Dr. Ananda Mohan Chakrabarty’s Birthday
2018-04-04
March 19, 1991: Genetic-Modified Bacteria E. Coli Granted by USPTO
2018-03-19
LATEST
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
nVent Electric Appoints New Chief Strategy and Revenue Officers
2026-06-10
Snail Games Announces Bellwright Console Launch and New ARK Content at IGN Live 2026
2026-06-10
BJJLink Launches AI-Powered Platform for Martial Arts Gym Member Acquisition
2026-06-10
Trump Media and TAE Technologies Provide Merger Status Update on June 10, 2026
2026-06-10
OZOP Energy Solutions Partners with Tenace Consulting for Southern California Distribution
2026-06-10
Agassi Sports Entertainment Signs Darren Cahill to Lead Global Coaching and Technology Initiatives
2026-06-10
Scroll to Top